BioSpace News Archive

Business

AbCellera Announces 25th Partnered Program and New Antibody Discovery Partnership with Global Biotech

AbCellera Biologics Inc. announced today a new therapeutic antibody discovery collaboration with an undisclosed mid-cap public biopharmaceutical company.

January 25, 2018
·
2 min read
Business

Canon Medical Systems Partners with QED to Accelerate Development of New, Innovative MRI Technology

Canon Medical Systems USA, Inc., in partnership with Quality Electrodynamics (QED), installed a Vantage GalanTM 3T MR system at the new QED Research Center in Mayfield Village, Ohio.

January 25, 2018
·
2 min read
FDA

Synergy Pharmaceuticals Announces FDA Approval of TRULANCE (Plecanatide) for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in Adults

Synergy Pharmaceuticals Inc. announced today that the FDA has approved TRULANCE (plecanatide) 3 mg tablet for the once-daily treatment of irritable bowel syndrome with constipation (IBS-C) in adults.

January 25, 2018
·
10 min read
Pharm Country

TOBA II BTK Trial Enrollment Ahead of Schedule for the Tack Endovascular System in Below the Knee Disease

Intact Vascular announced the Tack Optimized Balloon Angioplasty II Below the Knee (TOBA II BTK) clinical trial surpassed the 100 patient milestone, advancing enrollment well ahead of schedule.

January 25, 2018
·
3 min read
Business

Can-Fite Receives from Gebro Holdings $2,200,000 Payment as Part of Distribution Agreement for Piclidenoson in 3 European Countries

Can-Fite today announced it has received its first payment of approximately $2,200,000 from Gebro Holdings GmbH.

January 25, 2018
·
6 min read
Drug Development

The Medicines Company Release: Inclisiran’s First Pivotal Trial Achieves Target Enrollment Ahead of Schedule

The Medicines Company today announced that the target of 1,500 patients randomized in the ORION-11 trial has been exceeded in 11 weeks – considerably beating its goal of 28 weeks.

January 25, 2018
·
6 min read
Pharm Country

Soligenix - Driving Towards Key Inflection Points with Two Pivotal Phase 3 Clinical Trials

Soligenix today issued an update letter from its President and CEO, Dr. Christopher J. Schaber.

January 25, 2018
·
13 min read
ProMIS Neurosciences Issues White Paper Entitled: “Not All Amyloid Beta Therapeutics are Created Equal”

This is one of a series of commentaries from the ProMIS scientific team offering insight on Alzheimer’s disease science and the Company’s emerging product portfolio.

January 25, 2018
·
3 min read
Business

Celgene Reports Fourth Quarter and Full-Year 2017 Operating and Financial Results

For the fourth quarter of 2017, net product sales were $3,479 million, an increase of 17 percent, year-over-year.

January 25, 2018
·
33 min read
Business

3M Reports Fourth-Quarter 2017 Results; Raises 2018 Earnings Outlook

Fourth-quarter GAAP earnings were $0.85 per share, a decrease of 55 percent versus the fourth quarter of 2016.

January 25, 2018
·
25 min read